>Using the Drug Exclusion Provision on CBD may have opened the door for the FDA to make similar claims against NAC, but there is still the question of timing. W

>Using the Drug Exclusion Provision on CBD may have opened the door for the FDA to make similar claims against NAC, but there is still the question of timing. Why has the FDA chosen to target NAC now? In the past the provision was used inappropriately in three instances to protect the finances of pharmaceutical companies, and it is likely the motivation to ban NAC as a supplement has the same roots. I'm sure the provision will be used inappropriately many times.